← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-UTOfficial filing linked
John Curtis disclosed BUY $ABT
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$1K – $15K
Filed
2023-10-02
Trade date
2023-09-13
Disclosure lag
19 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 19 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
42 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for John Curtis, but PoliWealth treats it as context - not proof of intent or wrongdoing.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20023799 · filed 2023-10-02 · disclosed 19d after transaction
Market context
Abbott Laboratories
Factual flags
- 2 nearby same-ticker disclosures in the surrounding 30-day window.
- 9 trades filed on 2023-10-02 (batch dump)
Member trail
John Curtis
U.S. Senate · UT
Senate Committee on CommerceScienceand TransportationSenate Committee on Environment and Public WorksSenate Committee on Foreign RelationsSenate Committee on Small Business and Entrepreneurship
Ticker trail
$ABT
Company metadata pending
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.